“…After two additional washing steps, streptavidin‐Cy5 (Jackson Immuno Research, Cambridgeshire, UK) was added and samples were incubated for 5 min, followed by another two washing steps and addition of 1 ml PBS prior to analysis. As a control for FRET analysis, platelets were also incubated with two monoclonal antibodies (clone SZ22 and P2, Beckman‐Coulter, Krefeld, Germany) directed against different epitopes of the GPIIb/IIIa, and analysis of FRET efficacy was performed as described earlier (7, 8).…”